NCT05628948 Vascular Lab Resource (VLR) Biorepository
| NCT ID | NCT05628948 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Cleveland Clinic |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2019-11-14 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2019-11-14 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a study of biomarkers obtained from prospectively collected subject samples and their correlation with cardiovascular and metabolic diseases. The purpose of this initiative is to develop an enduring tool to allow for collaborative research between clinicians at Cleveland Clinic Main Campus and basic scientists at the Lerner Research Institute. This collaboration will allow resources to be available to clinical and basic researchers alike. This tool will enable research of vascular disease in the Vascular Lab and will leverage this valuable asset to the fullest extent to allow for interdepartmental collaboration.
Eligibility Criteria
Inclusion Criteria: 1. 18 years or older 2. Subjects capable of providing informed consent document 3. Subjects with diagnosed with or at risk for cardiovascular and metabolic diseases Exclusion Criteria: 1. Known life expectancy of ≤ 6 months at the time of enrollment 2. Known current pregnancy 3. Severe Anemia (last documented hemoglobin \< 7.0 g/dL)
Contact & Investigator
Scott Cameron, MD, PhD
PRINCIPAL INVESTIGATOR
The Cleveland Clinic
Frequently Asked Questions
Who can join the NCT05628948 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05628948 currently recruiting?
Yes, NCT05628948 is actively recruiting participants. Contact the research team at cameros3@ccf.org for enrollment information.
Where is the NCT05628948 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT05628948 clinical trial?
NCT05628948 is sponsored by The Cleveland Clinic. The principal investigator is Scott Cameron, MD, PhD at The Cleveland Clinic. The trial plans to enroll 500 participants.